Teladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Bokf Na

Bokf Na boosted its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 33.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 203,012 shares of the health services provider’s stock after acquiring an additional 51,196 shares during the quarter. Bokf Na’s holdings in Teladoc Health were worth $3,015,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. SG Americas Securities LLC lifted its holdings in Teladoc Health by 134.5% in the fourth quarter. SG Americas Securities LLC now owns 47,763 shares of the health services provider’s stock worth $1,029,000 after purchasing an additional 27,399 shares during the period. Oak Thistle LLC acquired a new stake in shares of Teladoc Health in the 4th quarter worth approximately $537,000. International Assets Investment Management LLC boosted its holdings in shares of Teladoc Health by 1,777.0% in the fourth quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider’s stock valued at $2,414,000 after acquiring an additional 106,069 shares in the last quarter. Sowell Financial Services LLC increased its stake in shares of Teladoc Health by 40.8% during the fourth quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock valued at $407,000 after acquiring an additional 5,475 shares during the period. Finally, Lecap Asset Management Ltd. acquired a new position in shares of Teladoc Health in the 4th quarter worth approximately $1,530,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded up $0.31 during midday trading on Monday, reaching $9.68. The company had a trading volume of 757,426 shares, compared to its average volume of 5,207,747. The stock has a fifty day simple moving average of $10.16 and a 200 day simple moving average of $14.01. Teladoc Health, Inc. has a 1-year low of $8.73 and a 1-year high of $30.15. The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $1.64 billion, a price-to-earnings ratio of -6.65 and a beta of 0.94.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. Teladoc Health’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.37) earnings per share. As a group, equities research analysts forecast that Teladoc Health, Inc. will post -1.05 earnings per share for the current year.

Insiders Place Their Bets

In other news, COO Michael Willem Waters sold 5,793 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $73,513.17. Following the sale, the chief operating officer now owns 64,881 shares of the company’s stock, valued at $823,339.89. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Teladoc Health news, COO Michael Willem Waters sold 5,793 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the sale, the chief operating officer now owns 64,881 shares in the company, valued at approximately $823,339.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the transaction, the director now owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 31,592 shares of company stock worth $383,854. Corporate insiders own 0.95% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on TDOC shares. Barclays dropped their price target on Teladoc Health from $25.00 to $20.00 and set an “overweight” rating on the stock in a report on Friday, April 26th. TD Cowen reduced their target price on Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a report on Friday, April 26th. JPMorgan Chase & Co. cut their price objective on Teladoc Health from $19.00 to $16.00 and set a “neutral” rating on the stock in a report on Tuesday, May 21st. Bank of America dropped their target price on shares of Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a research report on Tuesday, May 14th. Finally, Canaccord Genuity Group dropped their target price on Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, April 26th. Thirteen investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus price target of $17.97.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.